drugs.com vs webmd.com
Market traction comparison · Updated Jul 2026
| drugs.com | webmd.com | Leads | |
|---|---|---|---|
| Monthly Visits | 18.9M | 30.5M | webmd.com |
| Bounce Rate | 58.5% | 66.3% | drugs.com |
| SEO & Keywords | 30 | 30 | Tie |
| Domain Age | 27y 8m | 28y 5m | webmd.com |
webmd.com leads in 2 of 4 dimensions, while drugs.com leads in 1.
Growth Momentum
| drugs.com | webmd.com | Leads | |
|---|---|---|---|
| Monthly Visits | 18.9M | 30.5M | webmd.com |
| MoM Change | +11% | +3% | drugs.com |
| Avg. Session | 1m56s | 1m34s | drugs.com |
| Pages / Visit | 2.4 | 1.8 | drugs.com |
Growth Momentum · Insight
drugs.com is growing +11% while webmd.com grows +3%. At current trajectory, drugs.com could close the traffic gap within 10 months.
Acquisition Strategy
| drugs.com | webmd.com | Leads | |
|---|---|---|---|
| Primary Channel | Search 69% | Search 64% | |
| Bounce Rate | 58.5% | 66.3% | drugs.com |
| SEO & Keywords | 30 | 30 | — |
Keyword Overlap Rate: 400%
| Keyword | Volume | drugs.com | webmd.com |
|---|---|---|---|
| tamsulosin side effects | 6.6K | #5 | #10 |
| interactions | 4.3K | #1 | #7 |
Acquisition Strategy · Insight
drugs.com acquires users primarily through Search (69%), while webmd.com relies on Search (64%). This reflects fundamentally different go-to-market strategies — drugs.com's higher direct traffic suggests stronger brand recognition or product-led growth, while drugs.com's search reliance means growth is more scalable but more vulnerable to algorithm changes.
Business Maturity
| drugs.com | webmd.com | Leads | |
|---|---|---|---|
| Domain Age | 27y 8m | 28y 5m | webmd.com |
| Registered | Dec 1998 | Apr 1998 | |
| Expires | Dec 2026 | Apr 2027 |
Business Maturity · Insight
webmd.com has been in the market for over a decade, indicating established presence.
Market Position
| drugs.com | webmd.com | Leads | |
|---|---|---|---|
| Global Rank | #3.4K | #2.3K | webmd.com |
| Category Rank | #3 | #1 | webmd.com |
drugs.com only
webmd.com only
Market Position · Insight
Each has untapped markets the other serves: drugs.com could expand into Australia, while webmd.com could target Colombia.
Key Takeaways
- •drugs.com is growing +11% while webmd.com grows +3%. At current trajectory, drugs.com could close the traffic gap within 10 months.
- •drugs.com acquires users primarily through Search (69%), while webmd.com relies on Search (64%). This reflects fundamentally different go-to-market strategies — drugs.com's higher direct traffic suggests stronger brand recognition or product-led growth, while drugs.com's search reliance means growth is more scalable but more vulnerable to algorithm changes.
- •webmd.com has 1.6x more traffic (30.5M vs 18.9M), though both operate at comparable scale.
- •Both are growing, with drugs.com accelerating faster at +11% vs +3%.
- •They share 48 keywords (400% overlap), indicating direct search competition.
You've seen the gap. Now steal the playbook.
A Growth Teardown reverse-engineers exactly how each product grows — traffic sources, backlink strategy, keyword gaps, and scored action items you can copy this week.
Related Comparisons
Report based on data from July 2026